Cytomegaloviras interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells

Viral Immunology

Volumn 19, Issue 1, 2006, Pages 92-101

  Pepperl Klindworth, Sandra ^a   Besold, Katrin ^a   Frankenberg, Nadine ^a,b   Farkas, Mildred ^a   Kuball, Jürgen ^a,c   Theobald, Matthias ^a   Plachter, Bodo ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN; VIRUS RNA; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTING CELL; ARTICLE; BYSTANDER EFFECT; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DELETION MUTANT; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LYMPHOBLASTOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NORTHERN BLOTTING; SUPERNATANT; VIRUS MUTANT; ANTIGEN PRESENTATION; CELL CULTURE; CYTOLOGY; CYTOMEGALOVIRUS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; VIROLOGY;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BYSTANDER EFFECT; CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-10; MUTATION; VIRAL PROTEINS;

EID: 33645470203     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.92     Document Type: Article

References (52)

1. Ahn, K., A. Angulo, P. Ghazal, P.A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U.S.A. 93:10990-10995.
2. Ahn, K., A. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
3. Alcami, A., and U.K. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol. 8:410-418.
4. Arrode, G., C. Boccaccio, J.P. Abastado, and C. Davrinche. 2002. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells. J. Virol. 76:142-150.
5. Arrode, G., C. Boccaccio, J. Lule, S. Allart, N. Moinard, J.P. Abastado, A. Alam, and C. Davrinche. 2000. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J. Virol. 74:10018-10024.
6. Benz, C. and H. Hengel. 2000. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Virus Genes 21:39-47.
7. Benz, C., U. Reusch, W. Muranyi, W. Brune, R. Atalay, and H. Hengel. 2001. Efficient downregulation of major histocompatibility complex class I molecules in human epithelial cells infected with cytomegalovirus. J. Gen. Virol. 82:2061-2070.
8. Chang, W.L., N. Baumgarth, D. Yu, and P.A. Barry. 2004. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78:8720-8731.
9. Chee, M.S., A.T. Bankier, S. Beck, R. Bohni, C.M. Brown, R. Cerny, T. Horsnell, C.A. Hutchison, T. Kouzarides, J.A. Martignetti, E. Preddie, S.C. Satchwell, P. Tomlinson, K.M. Weston, and B.G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
10. Crumpacker, C. 2000. Cytomegalovirus, pp. 1586-1599. In: G.L. Mandell, J.E. Bennett, and R. Dolin (eds.). Principles and Practice of Infectious Diseases. Churchill-Livingstone, Philadelphia.
11. de Waal Malefyt. 2001. IL-10. pp. 165-185. In: J.J. Oppenheim and M. Feldman (eds.). Academic Press, San Diego.
12. Gilbert, M.J., S.R. Riddell, B. Plachter, and P.D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722.
13. Grundy, J.E., H.M. Ayles, J.A. McKeating, R.G. Butcher, P.D. Griffiths, and L.W. Poulter. 1988. Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection. J. Med. Virol. 25:483-495.
14. Hengel, H., W. Brune, and U.K. Koszinowski. 1998. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol. 6: 190-197.
15. Hengel, H., J.O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G.J. Hammerling, U.K. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623-632.
16. Hsu, D.H., M.R. de Waal, D.F. Fiorentino, M.N. Dang, P. Vieira, J. de Vries, H. Spits, T.R. Mosmann, and K.W. Moore. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832.
17. Jahn, G., E. Knust, H. Schmolla, T. Sarre, J.A. Nelson, J.K. McDougall, and B. Fleckenstein. 1984. Predominant immediate-early transcripts of human cytomegalovirus AD 169. J. Virol. 49:363-370.
18. Jones, B.C., N.J. Logsdon, K. Josephson, J. Cook, P.A. Barry, and M.R. Walter. 2002. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl. Acad. Sci. U.S.A 99:9404-9409.
19. Jones, T.R., E.J. Wiertz, L. Sun, K.N. Fish, J.A. Nelson, and H.L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U.S.A. 93:11327-11333.
20. Kotenko, S.V., C.D. Krause, L.S. Izotova, B.P. Pollack, W. Wu, and S. Pestka. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16:5894-5903.
21. Kotenko, S.V., S. Saccani, L.S. Izotova, O.V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U.S.A 97:1695-1700.
22. Lateef, Z., S. Fleming, G. Halliday, L. Faulkner, A. Mercer, and M. Baird. 2003. Orf virusencoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J. Gen. Virol. 84:1101-1109.
23. Lehner, P.J., J.T. Karttunen, G.W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processingdependent peptide translocation. Proc. Natl. Acad. Sci. U.S.A. 94:6904-6909.
24. Leland, D.S., and M.L.V. French. 1988. Virus Isolation and Identification, pp. 39-59. In: E.H. Lennette, P. Halonen, and F.A. Murphy (eds.), Laboratory Diagnosis of Infectious Diseases. Springer Verlag, New York.
25. Lockridge, K.M., S.S. Zhou, R.H. Kravitz, J.L. Johnson, E.T. Sawai, E.L. Blewett, and P.A. Barry. 2000. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280.
26. Loenen, W.A., C.A. Bruggeman, and E.J. Wiertz. 2001. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 13:41-49.
27. Michelson, S. 1999. Human cytomegalovirus escape from immune detection. Intervirology 42:301-307.
28. Mocarski, E.S., Jr. 2004. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol. 6:707-717.
29. Mocarski-ES, J. and C.T. Courcelle. 2001. Cytomegaloviruses and Their Replication, p. 2629-2673. In: D. M. Knipe and P. M. Howley (eds.) Virology. Lippincott Williams & Wilkins, Philadelphia.
30. Moore, K.W., M.R. de Waal, R.L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
31. Moore, K.W., P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230-1234.
32. Murthy, P.K., V.A. Dennis, B.L. Lasater, and M.T. Philipp. 2000. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 68: 6663-6669.
33. Pass, R.F. 2001. Cytomegalovirus, pp. 2675-2705. In: D.M. Knipe and P.M. Howley (eds.). Virology. Lippincott, Williams and Wilkins, Philadelphia.
34. Pepperl, S., J. Münster, M. Mach, J.R. Harris, and B. Plachter. 2000. Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J. Virol. 74:6132-6146.
35. Pepperl-Klindworth, S., N. Frankenberg, S. Riegler, and B. Plachter. 2003. Protein delivery by subviral particles of human cytomegalovirus. Gene Ther. 10:278-284.
36. Plachter, B. 1999. Immunevasion during cytomegalovirus infection. Biomed. Progr. 12:71-74.
37. Raftery, M.J., D. Wieland, S. Gronewald, A.A. Kraus, T. Giese, and G. Schonrich. 2004. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173:3383-3391.
38. Reddehase, M.J. 2000. The immunogenicity of human and murine cytomegaloviruses. Curr. Opin. Immunol. 12: 390-396.
39. Reddehase, M.J. 2002. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831-844.
40. Rode, H.J., W. Janssen, A. Rosen-Wolff, J.J. Bugert, P. Thein, Y. Becker, and G. Darai. 1993. The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like gene. Virus Genes 7:111-116.
41. Sinzger, C., M. Kahl, K. Laib, K. Klingel, P. Rieger, B. Plachter, and G. Jahn. 2000. Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J. Gen. Virol. 81 Pt 12:3021-3035.
42. Spencer, J.V., K.M. Lockridge, P.A. Barry, G. Lin, M. Tsang, M.E. Penfold, and T.J. Schall. 2002. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76:1285-1292.
43. Steinmassl, M. and K. Hamprecht. 1994. Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells. Arch. Virol. 135:75-87.
44. Tabi, Z., M. Moutaftsi, and L.K. Borysiewicz. 2001. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J. Immunol. 166:5695-5703.
45. Terhorst, C., P. Parham, D.L. Mann, and J.L. Strominger. 1976. Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc. Natl. Acad. Sci. U.S.A. 73: 910-914.
46. Theobald, M., J. Biggs, D. Dittmer, A.J. Levine, and L.A. Sherman. 1995. Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 92:11993-11997.
47. Weinshenker, B.G., S. Wilton, and O.P. Rice. 1988. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J. Immunol. 140:1625-1631.
48. Wiertz, E.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
49. Wiertz, E.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. Nature 384:432-438.
50. Wolff, D., G. Jahn, and B. Plachter. 1993. Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene. Gene 130:167-173.
51. Yu, D., M.C. Silva, and T. Shenk. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U.S.A. 100: 12396-12401.
52. Zhu, H., J.P. Cong, G. Mamtora, T. Gingeras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95:14470-14475.